BR9607336A - Composições de aminoácidos e utilidades das mesmas em nutrição clinica - Google Patents
Composições de aminoácidos e utilidades das mesmas em nutrição clinicaInfo
- Publication number
- BR9607336A BR9607336A BR9607336A BR9607336A BR9607336A BR 9607336 A BR9607336 A BR 9607336A BR 9607336 A BR9607336 A BR 9607336A BR 9607336 A BR9607336 A BR 9607336A BR 9607336 A BR9607336 A BR 9607336A
- Authority
- BR
- Brazil
- Prior art keywords
- tnf
- amino acid
- diminution
- levels
- acid compositions
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 230000035764 nutrition Effects 0.000 title 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 7
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000013632 homeostatic process Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08392694 US5656608B1 (en) | 1995-02-23 | 1995-02-23 | Amino acid compositions and methods of treatment using same |
| GBGB9512100.0A GB9512100D0 (en) | 1995-06-14 | 1995-06-14 | Improvements in or relating to organic compounds |
| PCT/EP1996/000739 WO1996025861A1 (en) | 1995-02-23 | 1996-02-22 | Amino acid compositions and use thereof in clinical nutrition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9607336A true BR9607336A (pt) | 1997-11-25 |
Family
ID=26307213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9607336A BR9607336A (pt) | 1995-02-23 | 1996-02-22 | Composições de aminoácidos e utilidades das mesmas em nutrição clinica |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0810829B1 (pt) |
| JP (1) | JPH11501301A (pt) |
| KR (1) | KR19980702436A (pt) |
| CN (1) | CN1175887A (pt) |
| AT (1) | ATE191615T1 (pt) |
| AU (1) | AU710527B2 (pt) |
| BR (1) | BR9607336A (pt) |
| CA (1) | CA2210499A1 (pt) |
| CZ (1) | CZ266797A3 (pt) |
| DE (1) | DE69607750T2 (pt) |
| DK (1) | DK0810829T3 (pt) |
| ES (1) | ES2145997T3 (pt) |
| FI (1) | FI972744L (pt) |
| HU (1) | HUP9800049A3 (pt) |
| NO (1) | NO973884L (pt) |
| PL (1) | PL182205B1 (pt) |
| PT (1) | PT810829E (pt) |
| WO (1) | WO1996025861A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9512100D0 (en) * | 1995-06-14 | 1995-08-09 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| EP0921794A1 (en) * | 1996-07-30 | 1999-06-16 | Novartis Nutrition AG | Amino acid composition and use thereof in treating tumor growth and metastasis |
| US6096785A (en) * | 1996-07-30 | 2000-08-01 | Novartis Nutrition Ag | Amino acid compositions and use thereof in treating renal dysfunction |
| GB9701674D0 (en) * | 1997-01-28 | 1997-03-19 | Novartis Nutrition Ag | Use of organic compounds |
| ES2221095T3 (es) * | 1997-06-05 | 2004-12-16 | Novartis Nutrition Ag | Glicina para prevencion o tratamiento del rechazo de transplantes. |
| EP1004301A4 (en) * | 1997-07-28 | 2002-11-13 | Riken | MEANS TO PROMOTE THE PROTECTION AND SURVIVAL OF THE CELLS OF THE CENTRAL VENTILATION SYSTEM |
| US6143786A (en) * | 1999-02-02 | 2000-11-07 | Novartis Nutrition Ag | Oral arginine and insulin secretion |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| JP4212470B2 (ja) | 2001-06-26 | 2009-01-21 | アムジェン フレモント インク． | Ｏｐｇｌへの抗体 |
| NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| DE10257360A1 (de) * | 2002-12-09 | 2004-07-08 | Fresenius Kabi Deutschland Gmbh | Gastro-intestinal verabreichbare Formulierung und deren Verwendung |
| WO2005023021A1 (ja) * | 2003-09-02 | 2005-03-17 | Bbk Bio Corporation | ダイエット食品 |
| EP1591118A1 (en) | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Use of melatonin in preventing postoperative complications |
| KR100555904B1 (ko) * | 2004-05-19 | 2006-03-03 | 주식회사 오스코텍 | 큰느타리버섯과 오가피의 혼합 생약재 추출물 및 이를유효성분으로 하는 골다공증 예방 및 치료용 조성물 |
| CN101472612B (zh) * | 2006-06-14 | 2011-06-08 | 纽崔西亚公司 | 包含甘氨酸和乳铁蛋白的抗炎组合物及其应用 |
| ES2773928T5 (es) | 2008-01-04 | 2023-06-28 | Nestle Sa | Composiciones que comprenden ácidos grasos insaturados y compuestos de liberación de óxido nítrico y uso de las mismas para la intensificación de las funciones cognitivas y relacionadas |
| US20100179089A1 (en) * | 2009-01-13 | 2010-07-15 | Deutz Nicolaas E P | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| MX375116B (es) * | 2009-06-08 | 2025-03-06 | Ucl Business Plc | Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina. |
| KR101213825B1 (ko) * | 2010-07-16 | 2012-12-18 | 서울대학교산학협력단 | 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물 |
| KR20170084354A (ko) | 2010-09-24 | 2017-07-19 | 유니버시티 오브 플로리다 리서치 파운데이션, 인크. | 위장 기능을 증진시키기 위한 물질 및 방법 |
| JP6378307B2 (ja) | 2013-03-11 | 2018-08-22 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 肺機能を改善するためならびに放射線誘発肺合併症の予防および／または処置のための物質および方法 |
| US20170326088A1 (en) | 2014-11-24 | 2017-11-16 | Entrinsic Health Solutions, Llc | Amino acid compositions for the treatment of symptoms of disease |
| US10500179B2 (en) | 2015-10-02 | 2019-12-10 | N. V. Nutricia | Glycine for use in tolerance induction in allergic patients |
| FR3041882B1 (fr) * | 2015-10-06 | 2019-04-12 | Universite D'angers | Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion |
| CN115645388B (zh) | 2016-10-04 | 2024-12-10 | 佛罗里达大学研究基金会公司 | 氨基酸组合物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2591893B1 (fr) * | 1985-12-19 | 1988-11-10 | Centre Nat Rech Scient | Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes |
| US4988724A (en) * | 1988-12-09 | 1991-01-29 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
| WO1993005780A1 (en) * | 1991-09-27 | 1993-04-01 | Board Of Regents, The University Of Texas System | Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| US5571783A (en) * | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
-
1996
- 1996-02-22 AT AT96904849T patent/ATE191615T1/de not_active IP Right Cessation
- 1996-02-22 CN CN96192066A patent/CN1175887A/zh active Pending
- 1996-02-22 WO PCT/EP1996/000739 patent/WO1996025861A1/en not_active Ceased
- 1996-02-22 CZ CZ972667A patent/CZ266797A3/cs unknown
- 1996-02-22 ES ES96904849T patent/ES2145997T3/es not_active Expired - Lifetime
- 1996-02-22 FI FI972744A patent/FI972744L/fi unknown
- 1996-02-22 BR BR9607336A patent/BR9607336A/pt not_active Application Discontinuation
- 1996-02-22 DE DE69607750T patent/DE69607750T2/de not_active Expired - Fee Related
- 1996-02-22 HU HU9800049A patent/HUP9800049A3/hu unknown
- 1996-02-22 PT PT96904849T patent/PT810829E/pt unknown
- 1996-02-22 JP JP8525404A patent/JPH11501301A/ja active Pending
- 1996-02-22 KR KR1019970705835A patent/KR19980702436A/ko not_active Ceased
- 1996-02-22 CA CA002210499A patent/CA2210499A1/en not_active Abandoned
- 1996-02-22 PL PL96321238A patent/PL182205B1/pl unknown
- 1996-02-22 EP EP96904849A patent/EP0810829B1/en not_active Expired - Lifetime
- 1996-02-22 DK DK96904849T patent/DK0810829T3/da active
- 1996-02-22 AU AU48795/96A patent/AU710527B2/en not_active Ceased
-
1997
- 1997-08-22 NO NO973884A patent/NO973884L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9800049A3 (en) | 1999-01-28 |
| CA2210499A1 (en) | 1996-08-29 |
| PT810829E (pt) | 2000-08-31 |
| NO973884D0 (no) | 1997-08-22 |
| WO1996025861A1 (en) | 1996-08-29 |
| FI972744A7 (fi) | 1997-08-22 |
| AU710527B2 (en) | 1999-09-23 |
| FI972744L (fi) | 1997-08-22 |
| CN1175887A (zh) | 1998-03-11 |
| KR19980702436A (ko) | 1998-07-15 |
| DK0810829T3 (da) | 2000-08-28 |
| DE69607750D1 (de) | 2000-05-18 |
| EP0810829B1 (en) | 2000-04-12 |
| EP0810829A1 (en) | 1997-12-10 |
| DE69607750T2 (de) | 2000-08-31 |
| NO973884L (no) | 1997-10-17 |
| FI972744A0 (fi) | 1997-06-25 |
| MX9706140A (es) | 1997-11-29 |
| JPH11501301A (ja) | 1999-02-02 |
| ES2145997T3 (es) | 2000-07-16 |
| PL321238A1 (en) | 1997-11-24 |
| AU4879596A (en) | 1996-09-11 |
| CZ266797A3 (cs) | 1998-03-18 |
| ATE191615T1 (de) | 2000-04-15 |
| PL182205B1 (pl) | 2001-11-30 |
| HUP9800049A2 (hu) | 1998-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9607336A (pt) | Composições de aminoácidos e utilidades das mesmas em nutrição clinica | |
| BG103335A (en) | Application of fumaric acid derivatives | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| IL112111A (en) | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them | |
| BRPI9908182B8 (pt) | composições de proteína de matriz para cura de feridas | |
| MX9504034A (es) | Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas. | |
| GB9806632D0 (en) | Peptide factor | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| EP0797999A3 (en) | Formulations of obesity protein | |
| AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
| MXPA99010523A (es) | Metodos para mejorar el funcionamiento del tractogastrointestinal superior. | |
| WO2006023665A3 (en) | Il-1 antagonist formulations | |
| MXPA02012064A (es) | Complejos de farmaco macromoleculares y composiciones que los contienen. | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| TR200101163T2 (tr) | Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları | |
| EP1285660A4 (en) | Zinc-supplementary compositions for oral administration | |
| ATE549036T1 (de) | Thymosin-alpha-1-peptid/polymer-konjugate | |
| Wildburger et al. | Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro | |
| MX9706971A (es) | Derivado de aminotetralina para la terapia de las enfermedades cardiovasculares. | |
| NO20016341L (no) | Inhibitorer for integrinet <alfa>v<beta>6 | |
| WO2003068160A3 (en) | Use of insulin-like growth factor binding protein 3 (igf-bp3) for inhibition of tumor growth | |
| WO1997040073A3 (de) | BIOLOGISCH AKTIVER EIWEISSSTOFF - KOLLAGENFRAGMENT HF-COLL-18/514cf - ZUR HEMMUNG DES WACHSTUMS VON TUMOREN UND VON GEFÄSSWUCHERUNGEN | |
| Wang et al. | Effects of arginine-devoid diets in chronically uremic rats | |
| DK521389A (da) | Praeparat til behandling af adrenoleukodystrofi | |
| BR9006746A (pt) | Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| FA8 | Dismissal: dismissal - article 36, par. 1 of industrial property law | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/198 (2006.01), A23L 33/12 (2016.0 |